Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
ALF Region Stockholm
Hjärt-Lungfonden
Vetenskapsrådet
Karolinska Institute
- License Information
-
More Information
Article History
Received: 15 October 2024
Accepted: 5 March 2025
First Online: 2 May 2025
Acknowledgements
: Some of the data were presented as an abstract at the EASD meeting in 2024.
: The data analysed in this study are based on Swedish nationwide registers. Individual-level data in the registers can only be accessed through secure servers, and only export of aggregated data, as presented in research articles, is allowed according to Swedish law. Permission to access data can be made only after fulfilling specific requirements to safeguard the anonymity of the study participants. For these reasons, data cannot be made generally available.
: Open access funding provided by Karolinska Institute. PU was supported by a grant from the Strategic Research Area Epidemiology programme and a Faculty Funded Career Position at Karolinska Institutet. BP was supported by a consolidator investigator grant from Karolinska Institutet. The study was conducted with research grant support from the Swedish Heart–Lung Foundation, the Swedish Research Council and ALF Region Stockholm.
: BE reports personal fees from Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Merck Sharp & Dohme, Novo Nordisk and Sanofi outside the scope of the submitted work. The remaining authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.
: C-EL and PU had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. C-EL, BP and PU designed the study. C-EL and PU drafted the manuscript. C-EL performed the statistical analysis. All authors contributed to the acquisition, analysis and interpretation of data, and to critical revision of the manuscript for important intellectual content. PU and BP obtained funding and supervised the study. All authors read and approved the final manuscript. The corresponding author attests that all listed authors meet authorship criteria and that no others meeting the criteria have been omitted.
